Detalles de la búsqueda
1.
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours.
Br J Cancer
; 124(4): 728-735, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33230210
2.
Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors.
Jpn J Clin Oncol
; 50(8): 859-866, 2020 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32328660
3.
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer.
Clin Cancer Res
; 30(4): 695-702, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38051750
4.
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors.
Int J Radiat Oncol Biol Phys
; 118(3): 743-756, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751793
5.
Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies.
Leuk Lymphoma
; 62(10): 2392-2399, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33896333
6.
Heterosis in early seed development: a comparative study of F1 embryo and endosperm tissues 6 days after fertilization.
Theor Appl Genet
; 120(2): 389-400, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19915820
7.
Validation of candidate genes putatively associated with resistance to SCMV and MDMV in maize (Zea mays L.) by expression profiling.
BMC Plant Biol
; 9: 15, 2009 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19187556
8.
Analysis of nonadditive protein accumulation in young primary roots of a maize (Zea mays L.) F(1)-hybrid compared to its parental inbred lines.
Proteomics
; 8(18): 3882-94, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18704907
9.
Variance component estimation for mixed model analysis of cDNA microarray data.
Biom J
; 50(6): 927-39, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19035549
10.
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial.
Target Oncol
; 10(2): 255-65, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25195590
Resultados
1 -
10
de 10
1
Próxima >
>>